A Team-based Approach to Treating HCV in Patients with End-Stage Renal Disease: Various Dates from October 12, 2017 - May 2, 2018

Increase your ability to Screen, Diagnose and Treat your Patients for Hepatitis C By Attending this Complimentary CME Event.
When Oct 12, 2017 06:30 PM to
May 02, 2018 08:30 AM
Where Various Dates and Locations - See Below
Contact Name
Add event to calendarvCal
iCal


Those who complete this activity will better understand how to screen, diagnose and treat the appropriate candidates with HCV under their care and when and how to refer to Hepatology for more advanced care.

Target Audience
Nephrologists, Gastroenterologists and Internists as well as related mid-level providers and nurse specialists.

CLICK HERE to view the Program Agenda and Learning Objectives

Registration Fees
There is no fee to attend these programs. Advance registration is requested to allow for event planning.

If online registration has closed you may still attend the event by registering as a walk-in the day of the program.

To Register
Click on a date and location below to register for a program.

October 12, 2017 - San Diego, CA - Online Registration for this Event is closed.
Click Here to view venue and speaker information

January 30, 2018 - Falls Church, VA - Online Registration for this Event is closed.
12:30 – 1:30pm
Inova Fairfax Hospital
Claude Moore Health Education Building – 3rd floor
3300 Gallows Road, Falls Church, VA 22042
Dr. Ira Jacobson, NYU Langone Health

February 1, 2018 -  Fresno, CA- Online Registration for this Event is closed. 
12:00 – 1:00pm
St. Agnes Medical Center
1303 E Herndon Ave, Fresno, CA 93720
Dr. Robert Gish, Stanford University School of Medline

February 28, 2018 - Reno, NV- Online Registration for this Event is closed.
5:30 – 6:30pm
Renown Regional Medical Center
1155 Mill Street, Reno, NV 89502
Dr. Robert Gish, Stanford University School of Medline

March 6, 2018 - Houston, TX- Online Registration for this Event is closed.
6:30 – 8:30pm
Briar Club
2603 Timmons Ln, Houston, TX 77027
Dr. Norman L. Sussman, Baylor University College of Medicine

March 20, 2018 - Scottsdale, AZ- Online Registration for this Event is closed. 
6:30 – 8:30pm
Scottsdale Hilton Resort
6333 N Scottsdale Road
Scottsdale, AZ
Dr. Hugo Vargas, Mayo Clinic-Scottsdale

March 28, 2018 – Union, NJ - Online Registration for this Event is closed.
Ristorante da Benito
222 Galloping Hill Rd.
Union, NJ
Dr. Nikolaos Pyrsopoulos, Rutgers New Jersey Medical School

April 18, 2018 – Jacksonville, FL - Online Registration for this Event is closed.
12:30 – 1:30pm
Mayo Clinic Florida
Walker Auditorium in the Davis Building
4500 San Pablo Road
Jacksonville, FL
Dr. Paul Martin, University of Miami Miller School of Medicine

May 2, 2018 - Aventura, FL
7:30 - 8:30am
Aventura Hospital and Medical Center
Biscayne Medical Arts Center
21110 Biscayne Blvd, Conf Room 101
Aventura, FL
Dr. Ram Bhamidimarri, University of Miami Miller School of Medicine

 
Joint Provider Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and SC Liver Research Consortia. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.

 Designation Statement
The University of Louisville Office of Continuing Medical Education & Professional Development designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 1.2 continuing education credits through University of Louisville Hospital, provider number 4-0068-7-18-1017. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content.

Jointly Provided By
UofL CMEPD logo          


Acknowledgments

This activity has been supported by grants from AbbVie and Merck.